Status:
COMPLETED
Comparison of 3 Methods to Assess Inhalation Technique
Lead Sponsor:
Medical University of Warsaw
Conditions:
Asthma
COPD
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
A significant percentage of patients with asthma and COPD do not use their inhalers properly. Experts recommend that in patients with obstructive lung diseases, inhalation technique and patient adhere...
Detailed Description
Asthma and chronic obstructive pulmonary disease (COPD) are common respiratory diseases. Inhaled therapy is the cornerstone of treatment in these two diseases. However, a significant proportion of pat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- informed consent for participating in the study
- age 18-85 years
- COPD or asthma diagnosed at least 3 months prior to enrollment
- using of at least one inhaler regularly every day
- using one of the inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI) or Metered Dose Liquid Inhalers (MDLI)
- Exclusion criteria:
- lack of informed consent
- age \<18 years or \> 85 years
- diagnosis of asthma or COPD not earlier than 3 months before enrollment
- using inhalers irregularly.
- symptoms of infection 5 days prior to beginning of the study
- comorbidity that could prevent patient from using Vitalograph®AIM to teach patient proper inhalation technique (i.e. advanced cognitive disorders, mental diseases, crucial neurological, vision or hearing disorders).
Exclusion
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04349735
Start Date
October 10 2019
End Date
December 30 2022
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw
Warsaw, Poland, 02-097